טוען...
Long‐acting beta2‐agonists as an inhaled corticosteroid‐sparing agent for chronic asthma in adults and children
BACKGROUND: The addition of a long acting beta agonist (LABA) to inhaled corticosteroid (ICS) therapy can improve asthma symptoms and reduce exacerbations. The addition of LABA may also have an ICS‐sparing effect and permit a reduction in ICS maintenance dose. OBJECTIVES: To determine the efficacy o...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2005
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387286/ https://ncbi.nlm.nih.gov/pubmed/16235393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005076.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|